Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jianfang Fu, Jie Yu, Xiang Zhang, Yaoyao Chang, Hongze Fan, Mengzhen Dong, Mengjia Li, Yue Liu & Jinxing Hu. (2023) Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Articles from other publishers (20)
Hongyan Lin, Dongxuan Ai, Qingqing Liu, Xinling Wang, Jiale Gao, Qingqing Chen, Lingyu Ruan, Yuheng Tao, Jian Gao & Liqun Wang. (2023) Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products 86:7, pages 1844-1854.
Crossref
Crossref
Li Gan, Qiyu Xiao, Yusong Zhou, Ying Fu & Mengjie Tang. (2023) Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration. Frontiers in Pharmacology 14.
Crossref
Crossref
Simiao Qiao, Yuying Hao, Linbo Cai, Xiaotong Duan, Lijuan Wang, Aidong Zhou & Xiaoxia Zhu. (2023) Prognostic value of cell-free DNA in cerebrospinal fluid from lung cancer patients with brain metastases during radiotherapy. Radiation Oncology 18:1.
Crossref
Crossref
Junyi Ren, Bo Wang, Qifeng Wu & Guiling Wang. (2022) Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug. Biomedicine & Pharmacotherapy 155, pages 113789.
Crossref
Crossref
Jennifer Novak, Ravi Salgia, Howard West, Miguel A Villalona-Calero, Sagus Sampath, Terence Williams, Victoria Villaflor, Erminia Massarelli, Ranjan Pathak, Marianna Koczywas, Brittney Chau & Arya Amini. (2022) Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC. Cancers 14:16, pages 3983.
Crossref
Crossref
Binfeng Liu, Zhongyue Liu, Chengyao Feng & Chao Tu. (2022) A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas. Frontiers in Genetics 13.
Crossref
Crossref
Qianfei Cui, Peng Song, Tiancheng Ma, Zefeng Wang, Xiaojing Lu, Yongjia Shi, Fang Zhang, Guoqiang Lin, Jiajia Dong & Jiange Zhang. (2022) Discovery of a Novel Potent Antitumor Molecule, P19G1, by Erlotinib Derivative Libraries Synthesized by Modular Click-Chemistry. Technology in Cancer Research & Treatment 21, pages 153303382211096.
Crossref
Crossref
Fang Zhou, Yunxia Zhang, Yanan Chen & Xiaolan Qian. (2021) Factors Associated with Cranial Nerve Injury after Radiotherapy for Large Brain Metastases. Journal of Healthcare Engineering 2021, pages 1-7.
Crossref
Crossref
Annina Seiler, Anil K. Sood, Josef Jenewein & Christopher P. Fagundes. (2020) Can stress promote the pathophysiology of brain metastases? A critical review of biobehavioral mechanisms. Brain, Behavior, and Immunity 87, pages 860-880.
Crossref
Crossref
Shaomin Zhang, Wei Jin & Yongjian Yang. (2019) Simultaneous identification and determination of eleven tyrosine kinase inhibitors by supercritical fluid chromatography-mass spectrometry. Analytical Methods 11:16, pages 2211-2222.
Crossref
Crossref
Bicky Thapa, Adam Lauko, Kunal Desai, Vyshak Alva Venur & Manmeet S. Ahluwalia. (2018) Novel Systemic Treatments for Brain Metastases From Lung Cancer. Current Treatment Options in Neurology 20:11.
Crossref
Crossref
Xueyan Wang, Ye Xu, Weiqing Tang & Lingxiang Liu. (2018) Efficacy and Safety of Radiotherapy Plus EGFR-TKIs in NSCLC Patients with Brain Metastases: A Meta-Analysis of Published Data. Translational Oncology 11:5, pages 1119-1127.
Crossref
Crossref
Stefano Fogli, Beatrice Polini, Marzia Del Re, Iacopo Petrini, Antonio Passaro, Stefania Crucitta, Eleonora Rofi & Romano Danesi. (2018) EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance. Pharmacogenomics 19:8, pages 727-740.
Crossref
Crossref
Ping‐Chih Hsu, Jinbai Miao, Zhen Huang, Yi‐Lin Yang, Zhidong Xu, Joanna You, Yuyuan Dai, Che‐Chung Yeh, Geraldine Chan, Shu Liu, Anatoly Urisman, Cheng‐Ta Yang, David M. Jablons & Liang You. (2018) Inhibition of yes‐associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model. Journal of Cellular and Molecular Medicine 22:6, pages 3073-3085.
Crossref
Crossref
Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
527
543
.
Ephraim Shmaya Lansky, Shifra Lansky & Helena Maaria PaavilainenEphraim Shmaya Lansky, Shifra Lansky & Helena Maaria Paavilainen. 2017. Harmal. Harmal
131
188
.
You-Guang Zheng, Jun Su, Cai-Yun Gao, Ping Jiang, Lin An, Yun-Sheng Xue, Jian Gao & Yi Liu. (2017) Design, synthesis, and biological evaluation of novel 4-anilinoquinazoline derivatives bearing amino acid moiety as potential EGFR kinase inhibitors. European Journal of Medicinal Chemistry 130, pages 393-405.
Crossref
Crossref
Qianqian Zhu, Yanan Sun, Yingying Cui, Ke Ye, Chengliang Yang, Daoke Yang, Jie Ma, Xiao Liu, Jinming Yu & Hong Ge. (2017) Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC). Oncotarget 8:8, pages 13304-13311.
Crossref
Crossref
Noboru Yamamoto, Koichi Goto, Makoto Nishio, Kenichi Chikamori, Toyoaki Hida, Makoto Maemondo, Nobuyuki Katakami, Toshiyuki Kozuki, Hiroshige Yoshioka, Takashi Seto, Kosei Tajima & Tomohide Tamura. (2016) Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer. International Journal of Clinical Oncology 22:1, pages 70-78.
Crossref
Crossref
Mark A. Socinski & Nathan A. Pennell. (2016) Best Practices in Treatment Selection for Patients with Advanced NSCLC. Cancer Control 23:4_suppl, pages 2-14.
Crossref
Crossref